Reportlinker.com announces that a new market research report is available in its catalogue: RNAi Technologies and Global Markets
STUDY GOALS AND OBJECTIVES
This BCC Research report, RNAi: Technologies and Global Markets, provides an overview of the current state of the RNA interference (RNAi) market, focusing specifically on RNAi research tools and reagents, drug discovery and diagnostics. It describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new potential trends in research and product development. This report also includes information regarding trends and obstacles affecting this market and its different sectors.
REASONS FOR DOING THE STUDY
Since its discovery, RNAi has become ubiquitous in biomedical research. RNAi provides benefits to the scientific research community and also has huge potential in therapeutics and diagnostics. The RNAi industry as a whole, however, has faced many difficulties in recent years. As the industry starts to warm up again in 2013, an updated comprehensive technology and business description is needed to better understand the field.
More therapeutics and diagnostics companies recognize the potential of RNAi, and thus they must understand the opportunities and challenges it presents. Insiders from both pharmaceutical companies and the RNAi industry will benefit from this study.
The RNAi market is part of general RNA market, but it has its own characteristics and unique competitive landscape. This report specifically covers RNAi, which is a very important gene-silencing mechanism. Researchers around the world use RNAi as a tool; moreover, pharmaceutical companies and agriculture companies have started to realize its potential in medicine and biotechnology.
This report highlights the main segments within the RNAi market:
Research tools and reagents.
RNAi drug delivery is discussed in one independent chapter due to its importance for drug development. Significant events and deals, as well as future trends and obstacles in the industry, are also discussed.
SCOPE OF REPORT
This report is a business tool that can help existing and potential market players to properly evaluate the commercial opportunities in the RNAi research tools and reagents, drug development, diagnostic and agriculture markets. The geographic scope is global. The RNAi market is complex, consisting of a number of different segments. Each segment is affected differently by technological and regulatory developments. This report identifies the main factors affecting each segment and forecasts market growth, future trends and product development in every major market segment.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used to prepare this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already-marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literatures, other product and promotional literature, annual reports, security analyst reports, and company websites. A patent search and analysis was also conducted.
In the second phase, a series of semi-structured interviews were conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotechnology and pharmaceutical companies. Other sources included academics, technology, and consulting companies. Subsequent analysis of the documents and interview notes was iterative.
This report is intended for business development professionals, entrepreneurs, and other investors who need to fully understand and properly evaluate each segment of the market for RNAi research tools reagents, drug developments, diagnostics and agriculture. It provides insights into the market position of major companies and presents new opportunities overlooked or less known to the business communities.
Dr. Faqing Yuan has more than 10 years of experience as a bench scientist specializing in RNA biochemistry, bio-nanotechnology and virology. He is the author of a number of scientific publications. He also holds an MBA degree from Queen's University of Canada.
This report provides:
An overview of the global market for RNAi technologies which are used in the areas of drug delivery, therapeutics, and diagnostics.
Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018.
A breakdown of the technologies: RNAi for drug delivery (by nanoparticle delivery, nucleic acid delivery, aptamer delivery); RNAi for drug discovery and therapeutics (by diseases); RNAi for disease diagnostics and biomarker development (by diseases); and RNAi for reagents, research tools, and other applications (by application).
Examination of significant deals in the RNAi technologies sector during the last decade.
Comprehensive company profiles of major players in the market.